Proliferative Diabetic Retinopathy (PDR) Completed Phase 2 Trials for Ranibizumab (DB01270)

Back to Proliferative Diabetic Retinopathy (PDR)

Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic

Indication	Status	Phase
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR))	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01594281	Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)	Treatment	Ranibizumab (DB01270)